Previous 10 | Next 10 |
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous (SQ) infusion solutions, today announced the appointment of Brent Rutla...
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”) , a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced its membership in the Subcutaneous (SC) Drug Development & Delivery C...
KORU Medical Systems, Inc. (KRMD) Q2 2022 Earnings Conference Call August 03, 2022, 16:30 ET Company Participants Gregory Chodaczek - Gilmartin Group Linda Tharby - President, CEO & Director Tom Adams - Interim CFO and VP, Financial Planning & Analysis ...
The following slide deck was published by KORU Medical Systems, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: KORU Medical Systems, Inc. 2022 Q2 - Results - Earnings Call Presentation
Repro Med Systems press release ( NASDAQ: KRMD ): Q2 Non-GAAP EPS of -$0.06 in-line. Revenue of $6.54M (+18.3% Y/Y) beats by $0.25M . Raising FY22 revenue guidance to $27.0 to 27.5 million For further details see: Repro Med Systems Non-GAAP EPS of -$0.06 ...
KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, to...
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report second quarter 2022 ...
Repro Med Systems, Inc. (KRMD) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Greg Chodaczek - Managing Director Linda Tharby - President & CEO Karen Fisher - CFO, Treasurer & Corporate Secretary Conference Call Participants Chase Knickerbocker - Craig-Ha...
Repro Med Systems press release (NASDAQ:KRMD): Q1 Non-GAAP EPS of -$0.05 beats by $0.01. Revenue of $6.24M (+14.9% Y/Y) beats by $0.17M. For further details see: Repro Med Systems Non-GAAP EPS of -$0.05 beats by $0.01, revenue of $6.24M beats by $0.17M
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of...
News, Short Squeeze, Breakout and More Instantly...
KORU Medical Systems Inc. Company Name:
KRMD Stock Symbol:
NYSE Market:
KORU Medical Systems Inc. Website:
2024-07-02 12:15:04 ET Canaccord Genuity analyst issues BUY recommendation for KRMD on July 2, 2024 10:05AM ET. The previous analyst recommendation was Buy. KRMD was trading at $2.25 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
2024-07-02 12:00:07 ET Kyle Rose from Canaccord Genuity issued a price target of $3.00 for KRMD on 2024-07-02 10:05:00. The adjusted price target was set to $3.00. At the time of the announcement, KRMD was trading at $2.25. The overall price target consensus is at $4.50 ...
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announ...